- Home
- AGIO vs CRTO Comparison
AGIO vs CRTO Comparison
Compare AGIO & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- CRTO
- Stock Information
- Founded
- AGIO 2007
- CRTO 2005
- Country
- AGIO United States
- CRTO France
- Employees
- AGIO N/A
- CRTO N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- AGIO Health Care
- CRTO Consumer Discretionary
- Exchange
- AGIO Nasdaq
- CRTO Nasdaq
- Market Cap
- AGIO 2.4B
- CRTO 2.5B
- IPO Year
- AGIO 2013
- CRTO 2013
- Fundamental
- Price
- AGIO $41.33
- CRTO $39.84
- Analyst Decision
- AGIO Hold
- CRTO Buy
- Analyst Count
- AGIO 5
- CRTO 9
- Target Price
- AGIO $52.50
- CRTO $51.75
- AVG Volume (30 Days)
- AGIO 585.1K
- CRTO 446.0K
- Earning Date
- AGIO 10-31-2024
- CRTO 10-31-2024
- Dividend Yield
- AGIO N/A
- CRTO N/A
- EPS Growth
- AGIO N/A
- CRTO 1230.66
- EPS
- AGIO N/A
- CRTO 1.65
- Revenue
- AGIO $31,306,000.00
- CRTO $1,956,857,000.00
- Revenue This Year
- AGIO $44.80
- CRTO N/A
- Revenue Next Year
- AGIO $174.95
- CRTO $6.88
- P/E Ratio
- AGIO N/A
- CRTO $23.53
- Revenue Growth
- AGIO 55.39
- CRTO 1.64
- 52 Week Low
- AGIO $19.80
- CRTO $22.10
- 52 Week High
- AGIO $53.29
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- AGIO 37.77
- CRTO 37.18
- Support Level
- AGIO $40.37
- CRTO $38.78
- Resistance Level
- AGIO $46.24
- CRTO $42.96
- Average True Range (ATR)
- AGIO 2.35
- CRTO 1.32
- MACD
- AGIO -0.66
- CRTO -0.20
- Stochastic Oscillator
- AGIO 7.39
- CRTO 44.15
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About CRTO Criteo S.A.
Headquartered in Paris, Criteo is one of the leading ad-tech companies in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.